Ciclotizolam
Clinical data | |
---|---|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 58765-21-2 |
PubChem (CID) | 71949 |
ChemSpider | 64956 |
UNII | JK517QTN4Q |
ChEMBL | CHEMBL2105986 |
Chemical and physical data | |
Formula | C20H18BrClN4S |
Molar mass | 461.806 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Ciclotizolam[1] (WE-973) is a drug which is a thienotriazolodiazepine derivative. It is a partial agonist for the benzodiazepine site of the GABAA receptor, with similar binding affinity to related compounds like brotizolam, but a low efficacy.[2][3]
See also
References
- ↑ DE Patent 2445430
- ↑ Weber KH, Kuhn FJ, Böke-Kuhn K, Lehr E, Danneberg PB, Hommer D, Paul SM, Skolnick P (February 1985). "Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines')". European Journal of Pharmacology. 109 (1): 19–31. doi:10.1016/0014-2999(85)90535-7. PMID 2986988.
- ↑ Ikeda M, Weber KH, Bechtel WD, Malatynska E, Yamamura HI (1989). "Relative efficacies of 1,4-diazepines on GABA-stimulated chloride influx in rat brain vesicles". Life Sciences. 45 (4): 349–58. doi:10.1016/0024-3205(89)90145-8. PMID 2569655.
This article is issued from Wikipedia - version of the 10/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.